<?xml version="1.0" encoding="UTF-8"?>
<p id="p0120">As of July 2018, the Global Fund had disbursed more than US $38 billion (
 <xref rid="bib21" ref-type="bibr">21</xref>) for HIV/AIDS, tuberculosis, malaria and health systems since its founding in 2002. However, no such financing entity or a financing facility exists for viral hepatitis, despite viral hepatitis being included in the Sustainable Development Goal 3.3(22) with these infections. Hence, to mount an effective large-scale response to hepatitis B, countries must move forward with alternative financing solutions (
 <xref rid="bib23" ref-type="bibr">23</xref>), alongside continued advocacy work, to include viral hepatitis on the agendas of global donors.
</p>
